Agenda I status unquestionably improves the level of complexity for virtually any analysis study. For example, all researchers—regardless of whether preclinical or medical—should receive Timetable I analysis registrations. 21 CFR portion 1301.18. In contrast, scientists who may have DEA Practitioner registrations in Schedules II–V (which most